UK regulator approves clinical trials for Ebola vaccine developed in eight weeks by Oxford scientists
MHRA approved Oxford's Ebola vaccine for phase one trials in 50 healthy UK adults, the first candidate to reach this stage after eight weeks of development.
14 JUL
· 3 min read
